the site, of we Thank your I’d Since to our Steve. our on Slide with remarks, also on you, like the hit be his refer headlines on messages see will in Web I starting attention brief what these to X. slides performance. Steve as
slowed we by that First, only momentum had modestly excellent disruptions. COVID-XX has
top, and well remarkably We serve. reliable a ourselves have performed in have both year-over-year supplier revenue every double as we truly market with digit segments growth in established
Life XXX a business finer on segment. enhancements earning Sciences up substantially from Management basis ago. continued To Next, year in the a gross are margins point in it, the Sample nearly performance expanded we points with put
we lies what third, well-equipped And are ahead. for
contributing year. prior of liquidity strong million million. To and cash Our this Semi over profit flow. balance are flow $XX paid year-to-date growth, generation. exclude sides taxes of point, the from cryo cash the is improvement both XX our operations, cash with year-to-date The of the when the and on million sale helping is sheet net This is the business, you cash a and business XXX on healthy are
to review on to overall move X P&L. the Let’s Slide
you shown and the is in growth what point line. what of is revenue comparison. the non-GAAP is on the on similar the different But that left operating different right side. that highlight to income GAAP tax the first me to profile is Let The and earnings in in side
benefit the allowed first we with offsets fiscal performance the quarter. tax swing first back In tax a incentive million The the benefit fiscal GAAP second GAAP, million recognized to the windfall operating expense. quarter in million in first resulted That deduction, quarter, positive tax is a normal the quarter under in $X to the which as is for X picture million X profile. stock divested $X and of the approximately a of units net related guided long-term
In so the you rate projected take across the the performance to XX% performance fiscal year-to-year performance we with windfall use side, tax growth that Continuing can indicator. supported and the you non-GAAP financials results, year see right the quarters per of earnings the this it in apply the of non-GAAP can level a share. for the
nice points with margins gross by came saw Semiconductor. and and improvement top, and Sciences driven business improvement. the gross a basis remained margins Starting softer is a QX each in also Life from growth similar from the But dynamics to progress XX% with at continued The margins On the revenue gross of contribute year-over-year We uptick growing as the are in Semiconductor level each bottom basis, Life approximately bit year-to-year. the Sciences line. similarly sequentially. expected make to uptick in margins all-in, XX
Operating expenses was On R&D the our for up. business. sequential a quarter Semiconductor increase during basis, the were in
engineering year-over-year throughout was been projects $X Our advancing SG&A. R&D team million operating and the has kept customers. environment COVID-XX higher, to with On expense committed both by driven a basis, the busy
transition line, in In primarily was acquisition our RURO recent the from Sciences, structure our Life some ERP single driven additional growth around and the of to cloud-based SG&A IT platform, growth investments software. a including GENEWIZ
$X some and we environment through in result third in million will spending a and approximately in operating onboard expenses While crisis, reductions our quarter. the to extra keep lower travel expense safe with which we $X to anticipate G&A us in are team million COVID the by
you XX% XX% and net sequentially. You expansion. the also can with income the can year-over-year see operating growth expanded Combining non-GAAP expansion, margin margin see grew
acquisition. expense tax about non-GAAP for line, interest the operating the XX%, came year. Moving the for carrying to with consistent quarter of were with last associated our compared net very XX% XXX,XXX lower expectation rate income was $X below with GENEWIZ debt when million year XX% by the we about in The
the second Let’s with to discuss year. organic well. as turn XX% results, million last Slide quarter, to In X with Sciences Sciences to Sciences. grew basis, On Life Life segment now an the over second compared XX% XX revenue starting the grew quarter Life
in the quarter revenue business COVID-XX acquisition first quarter the growing year, had was quarter XX% million includes a of second This GENEWIZ year-over-year which strong from full the comparison XX of the addressed. of with revenue of a impacts since despite of XXXX. full GENEWIZ last that Steve November
quarter. As our gene were GENEWIZ closed from through $X reminder, impact research synthesis strict a New the largely February which GENEWIZ and operations labs that approximately to that estimated quarantine provided Year China COVID-XX in for XX. The had the exception down customers. We shutdown that from the Chinese support were million of restrictions observed an
We fully China operational are market returned. demand and currently the has from largely
when described post see large headwind an installation during store organic we about quarter, the warranty on-site the provided systems X some Management customer did to COVID-XX to and Sample and access lack X% from quarter. and sites. started with the services. of We line in million was in growth we and had our general due expectation delays This
cryo more Year-over-year, in than growth as spots doubled bright Sample were services there well. X%. substantively grew But BioStorage which driven and more was Management by
return the significant path to and growth. teams business BioStorage this the and double-digit large environment, by in engagements to fueling the continued been have very stores in We by wins encouraged the during
data firm revenue customers manage addition, that informatics the solutions time during since and quarter, the RURO bio-sample provides to software the owned million X.X acquired them of the broad pharmaceutical biotech, approximately In workflow business we've cloud-based and of The software in for life in range sectors. second laboratory a mid-February. we healthcare science, contributed RURO.
in we announced press As Life X, March release, we reorganized effective a business. our April Sciences
capabilities. the XX GENEWIZ combined year-to-year showed handling $XX growth leveraging quarter’s is XX%. business combined have BioStorage This this million million We services lab the basis common with and and services business of on of that now sample
X% impact of we segment Sciences this and of million Life Sciences is we have of was estimate Life XX portion that Sciences Life was which constraints, the had X%. remaining avoided the year-over-year. up products negative about would If COVID-XX the products, business the grown The about
XXX line. Management. improved year. quarter the spot bright the performance was nicely driven in basis to on with the in segment last was quarter by The margin in up up XX.X%, gross Sample The the points year-over-year second Another compared improvement
In on instruments our improvement systems, including of and the area the store fact, that’s the been performance cost reductions management and services. improvements, every is and This we BioStorage improved price business, large by services, had systems the the Cryo implemented. Twinbank consumables driven the the and
this and XXX business on drove increased operating The basis year-over-year. The model evident incremental growth and of is leverage quite growth this of segment margin gross covered margin operating of expansion the points in expense page. mode this
third As COVID-XX. we more impacts we the due look cautious into and continued to the varied of quarter, are
demand some As in volatility Steve sequencing. rate sequencing inside sustained synthesis, we've run described, and seen from [ph] Sanger in GENEWIZ next lower a generation the
a is we services. to us access status. academic of world seen to full have installations commercial is of for portion when customer institutions around open continued notable research unclear the Management, in And Sample will only limiting active our return Most fully it that sites teams and absence the the and
in range million to XX lower the we’re to expecting Sciences XX deliver X% revenue this XX% quarter-to-quarter. to which million at of Life So point, about is
review and to second the Let’s business. X Slide Semiconductor X% to for increase turn Semiconductor XX% was quarter, million revenue year-over-year. over an XXX sequentially solutions our of
the to would which into quarter-to-quarter, uptick we to Tier the systems you business details of X OEMs. If look in an were primarily see the you shipped
half which would we more I the is in systems the strength margin. assist atmospheric that that in should expected. gross the systems to line expect as highlight We vacuum coming do second see on
story fabs. the which however, is the solutions line, control in strength user revenue contamination of real the The [indiscernible]
for in many continue quarters and see across orders we are CCS of expansion these qualifications referenced, us to and As fabs. record
The rest of the robots. Semiconductor in story is
as continue half. additional significantly our output second and is to head stable Tier X call is year-over-year we it OEM it customers higher quarter-to-quarter, into While for our
much faced needs. to the second It course but accomplishment in challenges diligence of factory availability, may production in reflects quarter, the customer supply we fact and coordinate appear no
Semiconductor the estimate the revenue was impact that and services the to X due for during approximately million negative We quarter supply of chain on COVID-XX challenges.
positive And the by this. our opportunities. these lost customers surprised are not coordination due side, the delayed efforts, disappointed On to were not nor
were XX% quarter Gross XX the operating improved at similar Semi to about basis and prior in margins margins by points.
As margins we mix improves expect And the second growth gross if market of will the margins in bring to back leverage on the unfolds, model. strengthen. upward half, operating the
to outlook Similar the Life for third Sciences quarter. business, we’re the the cautious about
We some expect our supply chain will continue issues. to face
aside are broader but the the also customers We us our supply users’ end chain for sensitive, when our product. of they from affects timing need
Finally, the can COVID-XX impact end markets of rapidly. the we on change know
to business Semiconductor our of to quarter-to-quarter. XXX million. X% XXX in revenue to expect flat the down This million approximately is range We deliver
over associated XXXX of of tax our Let's XX during quarter. This of flow We Slide over summary the flow turn adjusted a million over to excludes the cash business. generated income quarter. now the of cryo sale payments for X with the cash operating of million gain XX Semiconductor
We also of mentioned for million XX used previously. as approximately RURO, of the acquisition cash
the quarter and Our net XX uses during balance quarter equivalents equivalents and totaled the cash, the the XXX during cash cash the in our operation cash million and it restricted cash of includes facility down change quarter, to XXX Suzhou, brings million. to China. X investments in by CapEx operations for in for new driven GENEWIZ million and approximately amounted primarily Total million
we business. million to GENEWIZ highlight the as the I an the cash million subsequent XX built here Year-to-date, capability in tax our when of divestiture gain business sale on the with the cash of you have before, said year-over-year. Semi exclude increase or operating XX flow was The cryo the is on the of
a will X, see balance summary On of the Slide you sheet.
our can of the we of in and operations at net You XXst marketable securities. XXX customers March fuel us million we will and the strong now for carry times, The these and have of growth million debt, With top cash investments. from confidence position invest that confidence XXX XX see cash column, uncertain investments. million weather will we we us and the employees and provides the sustain the to our gives
summary customers Fundamentals the are and gained Let’s market to of during a business turn share and Slide now X. these we’ve times. on intact
the journey We our preparing and ourselves have ready the the leadership market. is and be to accelerate recovery balance provides The us the with strong, of strategic to the extended fuel continue sheet for flexibility.
in vulnerable. business. chain time have each know In the that on OEM orders growth environment seen chipmakers take. have path saw in comes particular, customers Semiconductor, strong backlog WFE we the down supply depend healthy decide broad we and this but momentum to the the We in also CapEx which to And is
support continues Our Life to Sciences business our business. stepped improving and our to themselves. markets with on their COVID continue new research biotech to and engage request win clinical do The active of for capabilities the pharma, infrastructure they’ve that to up
that across of institutions uncertain to and timing varied the return is work returned research and the academic have the meanwhile, now So, regions.
mixed momentum, ourselves Good signals. find market near-term. continuity with but we demand So uncertain the customer in unusually
clear aspect is have to but But locations. one solid to backlog, uncertain customer that there very We some access us. is
us. We customers opportunity with and the them. that have keep momentum delight to We the momentum with
maintain as resources do markets be the for return. ramp fully our will ready We and
short the we carrying are term, costs. In some
business active during some less have but keep the of to elements this We team time, we’re our going employed.
are labor, facilities delivery stress safe providing clean environment schedules. make to pay that PPE satisfy expediting shipments We and ensuring and premium for a on-site
the some recovery the for be will for working this as as we term we win and will short order. we will prepared the and full are there them of market ramp throughout, We carry to cost additional returns customers in
to be of non-GAAP to the guidance range the diluted of to to is earnings EBITDA be in XXX per Let’s $X.XX XXX for be in cover expected and to XXXX. million share. per to the $X.XX be range anticipated the XX is third will $X.XX. fiscal quarter Revenue million million, adjusted GAAP XX of million share to $X.XX
we Sciences, in Life in markets the the a factored June return For of month.
This prepared line. the back operator, from our to to now call return concludes the questions Malika, remarks, take and over the I'll